Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology.
about
Exosomal miRNAs as cancer biomarkers and therapeutic targetsAntibody-Based Assays for Phenotyping of Extracellular VesiclesDiagnostic technologies for circulating tumour cells and exosomes.Using exosomes, naturally-equipped nanocarriers, for drug deliveryFormation and role of exosomes in cancer.An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancerProgress in Exosome Isolation Techniques.Toward reliable biomarker signatures in the age of liquid biopsies - how to standardize the small RNA-Seq workflowNano-plasmonic exosome diagnosticsExtracellular vesicles in cardiovascular disease: are they Jedi or Sith?Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma.Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classificationA microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis.Plant derived edible nanoparticles as a new therapeutic approach against diseases.Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids.A Single-Cell Assay for Time Lapse Studies of Exosome Secretion and Cell Behaviors.The Drosophila Accessory Gland as a Model for Prostate Cancer and Other Pathologies.High-purity capture and release of circulating exosomes using an exosome-specific dual-patterned immunofiltration (ExoDIF) device.Exosome isolation: a microfluidic road-map.Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids.Emerging techniques in the isolation and characterization of extracellular vesicles and their roles in cancer diagnostics and prognostics.Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies.Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: Current status and future directions.Proteomic analysis of exosomal cargo: the challenge of high purity vesicle isolation.Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.Elucidating diversity of exosomes: biophysical and molecular characterization methods.A new approach in stem cell research-Exosomes: Their mechanism of action via cellular pathways.Advancements in microfluidics for nanoparticle separation.Bulk immunoassays for analysis of extracellular vesicles.The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients.Exosomes: promising sacks for treating ischemic heart disease?Phenotyping of Leukocytes and Leukocyte-Derived Extracellular Vesicles.Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating.Exosomal proteins as prognostic biomarkers in non-small cell lung cancerThe fourth annual BRDS on genome editing and silencing for precision medicines.The Exosome Total Isolation Chip.Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles.Lab-on-a-Chip Platforms for Detection of Cardiovascular Disease and Cancer Biomarkers.
P2860
Q26738660-A080C866-2391-4763-9442-CFEF02A2535DQ26771759-7160657D-7035-44AC-B835-FBDB7F985A65Q26776003-4AB05616-3557-46D3-89CB-6FAD449DF1DAQ28265872-9206929E-9197-4CDB-8C34-9277119B3DBFQ30303067-FEE05121-3364-4D09-A88A-ADE892E2313AQ30358093-FEE75740-6822-4236-8635-7D910AECC139Q30361993-43F89427-2976-4530-BD95-E79B6BED3B17Q30363613-AE77A344-72D0-41FA-B7C3-FA25D858CA32Q30396400-CD722300-E48D-4BD4-8C2F-A58FC7C6B962Q33362561-8B4D83A0-E867-4FC2-9279-72CF7DA688F3Q35143602-14B90AD3-DF0E-419E-99AD-2BE114402F1AQ36106782-C3212208-BB10-428A-8827-EC13DD7669BCQ36331875-49BFAC03-206F-4BF3-A7FD-95857AC35709Q36510465-D9D9F80F-9530-401A-8E8E-30D0CE0DA2C2Q37012929-F15D2C3A-69E6-4CED-9BE0-2CF10243D736Q37176960-8E0426C6-8BB3-46AE-8496-D99DF6C1D3E4Q37256232-4AEB4DB6-0436-4392-A8C0-6AA47B184578Q37577716-678D8978-AB9A-4DCC-AD53-B01FE33CD2B6Q38399057-56AF83FF-565F-4EE5-A602-585C7A3461ADQ38458786-AEE71129-A6D7-4F08-9A59-41AF198E1F1BQ38550197-A2DECA94-89DF-4685-90DC-51603478ED39Q38624837-AAFD8A94-98FB-4904-B2B2-F6456CA3A7BBQ38760869-22345A69-6222-4142-8432-ECCC9A5BF02CQ38770359-956A7FF7-0332-4139-9052-06B300338BC8Q38794211-53D38368-00F1-4BD6-9403-B39ED57DD461Q38842241-54AECDCF-EB81-45F8-9075-9DEA5B32A754Q38917377-6BACCE5A-17AF-43E9-AAEC-745C9BF767D2Q38964517-19CCD212-0A0C-496A-A4C7-DA6A6E7A8176Q39004365-AF633AB1-7E44-4EDE-825D-598C71194EB1Q39094989-43DEDACD-A759-400D-8546-A23DCBCF9F6DQ39123707-5A59E620-141D-4F75-AE7E-EAFFC7AC6AECQ39166735-EF2D19F4-FCBF-47B4-B274-74609DC788BCQ39395324-C3B30D19-B81D-4A91-999A-4686886AA00EQ39754230-B0367162-2FB4-4E28-B838-0EBB3CABAA44Q41891729-FE34A095-4CF0-4C8D-B7FA-319002F92AF8Q42282902-912A2DE9-0D38-4457-BF89-D081A9161709Q45875491-CB545E6B-0A02-40BB-A1D2-36CA9C134F81Q46672367-E1E3F41C-DCD2-458D-897A-37D16AA15835Q47250358-C6267F41-C10F-4525-B446-82FC79BB42D1Q47274844-6C3B5650-5571-4053-B613-382A8A9C6189
P2860
Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Integrated immunoisolation and ...... using microfluidic technology.
@ast
Integrated immunoisolation and ...... using microfluidic technology.
@en
Integrated immunoisolation and ...... using microfluidic technology.
@nl
type
label
Integrated immunoisolation and ...... using microfluidic technology.
@ast
Integrated immunoisolation and ...... using microfluidic technology.
@en
Integrated immunoisolation and ...... using microfluidic technology.
@nl
prefLabel
Integrated immunoisolation and ...... using microfluidic technology.
@ast
Integrated immunoisolation and ...... using microfluidic technology.
@en
Integrated immunoisolation and ...... using microfluidic technology.
@nl
P2093
P2860
P356
P1433
P1476
Integrated immunoisolation and ...... using microfluidic technology.
@en
P2093
Andrew K Godwin
Jennifer Crow
P2860
P304
P356
10.1039/C4LC00662C
P577
2014-10-01T00:00:00Z